Reaktion #358092

ord-9ff822e0666b44b9a3e257ef137183c0

Reaktionsgleichung

CN(C)C=O
DMF
FC(F)(F)c1[nH]nc(-c2ccccc2)c1Br
4-Bromo-3-phenyl-5-trifluoromethyl-1H-pyrazole
O=C([O-])[O-].[K+].[K+]
K2CO3
COc1cc(N2CCN(C(=O)CCl)CC2)ccc1Cl
2-Chloro-1-[4-(4-chloro-3-methoxy-phenyl)-piperazin-1-yl]-ethanone
COc1cc(N2CCN(C(=O)Cn3nc(-c4ccccc4)c(Br)c3C(F)(F)F)CC2)ccc1Cl
title compound
COc1cc(N2CCN(C(=O)Cn3nc(-c4ccccc4)c(Br)c3C(F)(F)F)CC2)ccc1Cl
1-[4-(4-Chloro-3-methoxyphenyl)-piperazin-1-yl]-2-(4-bromo-3-phenyl-5-trifluoromethyl-pyrazol-1-yl)-ethanone

Lösungsmittel

Reaktionsbedingungen

Detaillierte Bedingungen
See reaction.notes.procedure_details.

Vorschrift

Protocol T was followed using 4-Bromo-3-phenyl-5-trifluoromethyl-1H-pyrazole, K2CO3, 2-Chloro-1-[4-(4-chloro-3-methoxy-phenyl)-piperazin-1-yl]-ethanone and DMF. Column chromatography using a solvent mixture (hexane/ethyl acetate=1/1, Rf=0.51) afforded the title compound as a white solid. 1H NMR (400 MHz, CDCl3): 7.42-7.52 (m, 5H), 7.18-7.22 (d, 1H), 6.38-6.42 (dd, 1H), 6.46-6.48 (d, 1H), 4.94 (s, 2H), 3.88 (s, 3H), 3.5-3.78 (m, 4H), 3.18 (s, 4H).

Quelle

DOI: 10.6084/m9.figshare.5104873.v1Patent: US07449576B1uspto-grants-2008_11